Robert Sato

Bob Sato joined Codexis in 2007 as the Director of Analytical Development & Quality Control and his responsibilities have since expanded to include Quality and Regulatory. He brings close to 30 years of fine chemical and pharmaceutical industry experience in GMP Quality Control, analytical development, physicochemical characterization and preformulation/formulation development. His pharmaceutical development work has contributed to a wide range of successful regulatory filings in the therapeutics space, most recently where he provided crucial support leading to the success of Codexis’ first Phase I clinical trial.